Suppr超能文献

抗凝治疗的老年患者发生创伤性颅脑损伤:一种致命组合。

Traumatic head injury in the anticoagulated elderly patient: a lethal combination.

作者信息

Karni A, Holtzman R, Bass T, Zorman G, Carter L, Rodriguez L, Bennett-Shipman V J, Lottenberg L

机构信息

Memorial Regional Trauma Center, Hollywood, Florida, USA.

出版信息

Am Surg. 2001 Nov;67(11):1098-100.

Abstract

Warfarin is the most common oral anticoagulant used for chronic anticoagulation therapy. Even without any antecedent trauma overanticoagulation can result in intracranial hemorrhage. The triad of anticoagulation with warfarin, age greater than 65 years, and traumatic head injury frequently produces a lethal brain hemorrhage. A retrospective review of more than 2000 patients admitted to the Trauma Service between September 1998 and May 2000 produced 278 patients with head injury and CT-documented intracranial hemorrhage. Of these patients 21 were admitted with an elevated prothrombin time (PT) due to anticoagulation with warfarin. Eighteen patients (86%) were above the age of 70. The most common indications for anticoagulation were atrial fibrillation (71%), deep venous thrombosis (19%), aortic valve replacement (9%), and ischemic cerebral infarcts (9%). Fourteen injuries were the result of a fall, one resulted from a gunshot wound, and one resulted from an assault. The remaining five patients were excluded as their history, workup, and evaluation by neurosurgery suggested a spontaneous bleed leading to fall rather than a fall causing a traumatic bleed. The average Glasgow Coma Score on admission was 11. The average PT and International Normalized Ratio (INR) on admission were 19.2 and 2.99 respectively. Eight of the 16 patients analyzed died. The risk of intracranial hemorrhage with relatively minor head injury is increased dramatically in the anticoagulated patient. A mortality rate of 50 per cent far exceeds the mortality rate in patients with similar head injuries who are not anticoagulated. In addition the risk/benefit equation of anticoagulation for the elderly is more complex and differs from that for younger patients. Perhaps more frequent and judicious monitoring of prothrombin time levels with lower therapeutic ranges (INR 1.5-2) is necessary.

摘要

华法林是用于慢性抗凝治疗最常用的口服抗凝剂。即使没有任何先前的外伤,抗凝过度也可能导致颅内出血。使用华法林进行抗凝、年龄大于65岁以及创伤性颅脑损伤这三者常常会引发致命性脑出血。对1998年9月至2000年5月间创伤科收治的2000多名患者进行回顾性研究,发现278例头部受伤且CT证实有颅内出血的患者。其中21例因使用华法林抗凝而入院时凝血酶原时间(PT)升高。18例患者(86%)年龄在70岁以上。抗凝最常见的适应证为房颤(71%)、深静脉血栓形成(19%)、主动脉瓣置换(9%)和缺血性脑梗死(9%)。14例损伤是跌倒所致,1例由枪伤引起,1例由袭击导致。其余5例患者被排除,因为他们的病史、检查以及神经外科评估提示是自发性出血导致跌倒,而非跌倒引起创伤性出血。入院时平均格拉斯哥昏迷评分是11分。入院时平均PT和国际标准化比值(INR)分别为19.2和2.99。分析的16例患者中有8例死亡。在抗凝患者中,相对轻微的头部损伤导致颅内出血的风险会显著增加。50%的死亡率远远超过未抗凝的类似头部损伤患者的死亡率。此外,老年人抗凝的风险/获益权衡更为复杂,与年轻患者不同。或许有必要更频繁且审慎地监测凝血酶原时间水平,采用较低的治疗范围(INR 1.5 - 2)。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验